Medtronic plc (MDT) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Medtronic shareholders at a glance

The largest holder of Medtronic stock is Vanguard Capital Management LLC, with 96.4 million shares (7.51% of the company), worth about $7.81 billion as of May 18, 2026. The 10 largest holders together own 41.3%.

In Q2 2026, 2,222 institutional holdings reports listed 1.27 billion shares worth $89.90 billion, up 15.5% in shares from Q1 2026.

Insiders reported 74 transactions in the last two years: 8 sales worth $11.62 million and 1 purchase. The newest one on file is from September 16, 2026 (Kiil Harry Skip, Officer).

Major holders as of May 18, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through September 16, 2026.

MDT logo

Medtronic plc

MDTIreland
Healthcare

Shareholders Summary

2026Q2

Filings
2222
Options Value
$1.50B
Value (excl. Options)
$89.90B
Shares (excl. Options)
1.27B

Ownership by Type

Geographic Distribution

Largest Medtronic shareholders

HolderShares% of companyValue
Vanguard Capital Management LLC96.4 million7.51%$7.8B
BlackRock Advisors LLC84.1 million6.55%$6.8B
Vanguard Capital Management LLC83.3 million6.49%$6.7B
State Street Corporation61.7 million4.81%$5.0B
JPMorgan Investment Management, Inc.51.0 million3.97%$4.1B
Capital Research & Management Co. (Global Investors)41.9 million3.27%$3.4B
Vanguard Portfolio Management LLC33.5 million2.60%$2.7B
Geode Capital Management LLC28.7 million2.24%$2.3B
Merrill Lynch International24.7 million1.92%$2.0B
BlackRock Life Ltd.24.4 million1.90%$2.0B

As of May 18, 2026.

Medtronic institutional holdings by quarter

QuarterReportsSharesValue
Q2 20262,2221.27 billion$89.9B
Q1 20262,3301.10 billion$95.7B
Q4 20252,4111.10 billion$105.0B
Q3 20252,2851.13 billion$107.0B
Q2 20252,2461.10 billion$95.8B
Q1 20252,2751.08 billion$98.5B
Q4 20242,2231.07 billion$85.4B
Q3 20242,1691.09 billion$97.6B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Medtronic insider trades

InsiderDateTitleTransactionValue
Kiil Harry SkipSep 16, 2026OfficerSale at price 93.65 per share.$138,883
Blomquist Denise LSep 15, 2026OfficerStock Gift at price 0.00 per share.–
Thompson KweliAug 3, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Martha Geoffrey SAug 3, 2026Chief Executive OfficerStock Award(Grant) at price 0.00 per share.–
Quinn MichelleAug 3, 2026General CounselStock Award(Grant) at price 0.00 per share.–
Marinaro MichaelAug 3, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Walter Matthew R.Aug 3, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Pieton Thierry Jean LouisAug 3, 2026Chief Financial OfficerStock Award(Grant) at price 0.00 per share.–
Blomquist Denise LAug 3, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Kiil Harry SkipAug 3, 2026OfficerStock Award(Grant) at price 0.00 per share.–
Walter Matthew R.Jul 8, 2026OfficerSale at price 83.15 per share.$257,931
Kiil Harry SkipJun 8, 2026OfficerSale at price 80.44 - 80.45 per share.$336,965

Newest 12 of 74 insider transactions in the last two years.

Questions and answers

Who owns the most Medtronic stock?

Vanguard Capital Management LLC, with 7.51% of the company (as of May 18, 2026). Next: BlackRock Advisors LLC (6.55%) and Vanguard Capital Management LLC (6.49%).

How many institutions own Medtronic stock?

2,222 institutional holdings reports listed Medtronic shares in Q2 2026, 1.27 billion shares in all worth $89.90 billion.

Are Medtronic insiders buying or selling the stock?

In the last two years insiders reported 8 sales and 1 purchase (74 transactions in all); the newest on file is from September 16, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube